Amniotic Membrane Wound Care Products in Rochester, NY

CDC PLACES vs. JK: two files, not one brochure

Joe Bradley will tell you the same thing he tells his own staff: epidemiology first, then MAC, then SKU. CDC PLACES (2023, crude) estimates 14.3% of adults in Rochester have diagnosed diabetes — 2.3 points above the U.S. 12% figure. 10.9% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. Then we pick amniotic membrane wound care against that mix.

Where Rochester programs actually stall

• CDC PLACES (2023, crude) estimates 14.3% of adults in Rochester have diagnosed diabetes — 2.3 points above the U.S. 12% figure. Adult obesity in Rochester is 38% (CDC PLACES 2023). That shows up in wound offloading and in joint-preservation volume — not as a slogan. A CTP without offloading and serial measurements still fails JK review. Product is the last step, not the first.
• JK (National Government Services (NGS)) is the contractor that will review CTP units, application frequency, and wound measurements for New York Part B claims. Practices that skip MAC education typically see denials before they see outcomes.
• Staff turnover in a city under 250k makes “we trained them last year” a weak control. HCT/P handling, centrifuge SOPs, and wound-photo standards need a named owner in the practice, not a one-time in-service.

Uninsured mix and Medicare CTPs in the same building

America’s Health Rankings (BRFSS 2024) only publishes state diabetes as a range nationally (Colorado 8.4% to West Virginia 18.4%). For Rochester we use CDC PLACES instead of interpolating a fake city rate from that range. CDC PLACES (2023, crude) estimates 14.3% of adults in Rochester have diagnosed diabetes — 2.3 points above the U.S. 12% figure.

How we’d stand this up in clinic